Role of therapeutic drug monitoring (TDM) in pediatric anti-convulsant drug dosing
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Brain & Development
- Vol. 16 (1) , 23-26
- https://doi.org/10.1016/0387-7604(94)90108-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phenobarbital Doses Necessary to Achieve 'Therapeutic' Concentrations in ChildrenDevelopmental Pharmacology and Therapeutics, 1991
- Valproic Acid Dosages Necessary to Maintain Therapeutic Concentrations in ChildrenTherapeutic Drug Monitoring, 1991
- Carbamazepine Age-Dose Ratio Relationship in ChildrenTherapeutic Drug Monitoring, 1991
- Neonatal Therapeutic Drug Monitoring—Its Clinical RelevanceTherapeutic Drug Monitoring, 1989
- Providing Effective Therapeutic Drug Monitoring ServicesTherapeutic Drug Monitoring, 1989
- Carbamazepine Plasma ConcentrationArchives of Neurology, 1987
- Effects of Single Large Doses of Phenytoin on Glucose Homeostasis—a Preliminary ReportThe Journal of Clinical Pharmacology, 1982
- Effect of dose on phenytoin absorptionClinical Pharmacology & Therapeutics, 1980
- Once daily doses of phenobarbital in childrenThe Journal of Pediatrics, 1980
- Phenytoin kinetics in childrenNeurology, 1976